Clinical trial · Observational
Ultra-low-dose Whole-body CT Using AI-based CT Reconstruction in Patients With Multiple Myeloma
Noise Reduction and Image Quality Improvement in Ultra-low-dose Whole-body CT Scans Using AI-based CT Reconstruction Program (ClariCT.AI) in Patients With Multiple Myeloma: A Prospective, Single-center Study
NCT05577884CI-TRIAL-00062048unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This prospective study aims to perform intra-individual comparison of the image quality between ultra-low-dose whole-body CT with deep learning reconstruction and conventional low-dose whole-body CT with iterative reconstruction in patients with suspected multiple myeloma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Multiple Myeloma | Multiple Myeloma | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| noncontrast-enhanced whole-body CT | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Multiple myeloma
- description
- Patients with suspicion of multiple myeloma and scheduled for CT
- interventionNames
- Diagnostic Test: noncontrast-enhanced whole-body CT
Primary outcomes (1)
- measure
- Contrast-to-noise ratio
- timeFrame
- 3 months after the CT scan
- description
- Contrast-to-noise ratio (CNR) of the vertebral body and paraspinal muscle obtained at L1 vertebra level
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * signed informed consent * patients with suspected multiple myeloma and scheduled for noncontrast-enhanced low-dose whole-body CT * patients who have no previous history of chemotherapy for multiple myeloma Exclusion Criteria: * patients who do not agree to the protocol * non-Korean patients * pregnancy
References
Publications (0)
Data not yet available
No reference posted for this study.